New York legislation · 2025-2026 General Assembly
New York A5882: Relates to payments by a pharmacy benefit manager to participating pharmacies
Status: In committee, June 4, 2026
Requires a pharmacy benefit manager to pay a participating pharmacy at minimum at the national average drug acquisition cost (NADAC) rate, or at the pharmacy acquisition cost rate if greater or there is not a NADAC rate, plus a professional dispensing fee that is at minimum the professional dispensing fee paid under the state medical assistance program.
What the bill says
An act to amend the public health law and the insurance law, in relation to payments by pharmacy benefit managers to participating pharmacies.
From the amended text, February 24, 2026:
AN ACT to amend the public health law and the insurance law, in relation to payments by pharmacy benefit managers to participating pharmacies THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEMBLY, DO ENACT AS FOLLOWS: Section 1. Subdivision 1 of section 280-a of the public health law is amended by adding two new paragraphs (j) and (k) to read as matter in brackets [ ] is old law to be omitted. LBD01972-10-6 A. 5882--C 2 (J) "PHARMACY ACQUISITION COST RATE" MEANS THE COST PAID BY A PARTICIPATING PHARMACY TO ACQUIRE GENERIC, BRAND NAME DRUGS, OR BIOLOGIC PRODUCTS, OR DRUGS PRODUCED THROUGH GENETIC TECHNOLOGY OR BIOPHARMACEUTICAL PROCESSES PURSUANT TO COST INVOICES FROM THE PHARMACY. (K) "NATIONAL AVERAGE DRUG ACQUISITION COST" MEANS THE MONTHLY SURVEY OF RETAIL PHARMACIES CONDUCTED BY THE FEDERAL CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) TO DETERMINE AVERAGE ACQUISITION COST FOR MEDICAID COVERED OUTPATIENT DRUGS. § 2. Subdivision 3 of section 280-a of the public health law, as amended by chapter 128 of the laws of 2022, is amended to read as follows: 3. Prescriptions. (A) A pharmacy benefit manager may not substitute or cause the substituting of one prescription drug for another in dispensing a prescription, or alter or cause the altering of the terms of a prescription, except with the approval …
Sponsors
- John McDonald (D, 108) · primary sponsor
- Carrie Woerner (D, 113)
- Paul Bologna (R, 144)
- Landon Dais (D, 77)
- Judy Griffin (D, 21)
- Andrew Hevesi (D, 28)
- Albert Stirpe (D, 127)
- Grace Lee (D, 65)
- Paula Kay (D, 100)
- Karl Brabenec (R, 98)
- Marianne Buttenschon (D, 119)
- Maryjane Shimsky (D, 92)
Latest actions
- : SUBSTITUTED BY S5939C
- : ORDERED TO THIRD READING RULES CAL.483
- : RULES REPORT CAL.483
- : REPORTED
- : REPORTED REFERRED TO RULES
- : REPORTED REFERRED TO WAYS AND MEANS
- : PRINT NUMBER 5882C
- : AMEND AND RECOMMIT TO INSURANCE
- : REFERRED TO INSURANCE
- : REFERENCE CHANGED TO INSURANCE
Votes
- Assembly Ways And Means Committee: Favorable refer to committee Rules (June 4, 2026): 32 yea, 0 nay, passed
- Assembly Rules Committee: Favorable (June 4, 2026): 28 yea, 0 nay, passed
- Assembly Insurance Committee: Favorable refer to committee Ways and Means (May 20, 2026): 22 yea, 0 nay, passed
Subjects: Public Health Law
Common questions
- What is A5882?
- A5882 is a bill in the New York Legislature (2025-2026 General Assembly): Relates to payments by a pharmacy benefit manager to participating pharmacies.
- What does A5882 do?
- In its own words: An act to amend the public health law and the insurance law, in relation to payments by pharmacy benefit managers to participating pharmacies.
- What is the status of A5882?
- In committee as of June 4, 2026. Latest action: SUBSTITUTED BY S5939C (June 4, 2026).
- Who sponsored A5882?
- John McDonald (D, 108), with 11 co-sponsors.
- Where is the official record for A5882?
- On the New York Legislature website: https://www.nysenate.gov/legislation/bills/2025/A5882
Source: official New York record. Tracked by Delilah, AI for legislation across all 50 states and Congress.